Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -57.17% is 38% below its 4-year average of -41.31%, around the middle of its 4-year range (-100.60%–-13.13%).
As of the fiscal period ended Tuesday, June 30, 2026. 38.01% below its 12-month average of -41.43%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -57.17%.
RETURN ON INVESTED CAPITAL (ROIC)
-57.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-41.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-45.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-38.01%
CURRENT VS 3Y AVG
-25.23%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 761 covered companies
CURRENT VS SECTOR MEDIAN
-64.43%
vs the sector median at left
Mineralys Therapeutics, Inc.
Market Cap
$1.97B
Return on Invested Capital (ROIC)
-57.17%
TTM Avg
-41.43%
3Y Avg
-45.66%
5Y Avg
N/A
Market Cap
$1.98B
Return on Invested Capital (ROIC)
6.33%
TTM Avg
5.44%
3Y Avg
-1.33%
5Y Avg
-7.01%
Market Cap
$1.96B
Return on Invested Capital (ROIC)
-4.68%
TTM Avg
-2.93%
3Y Avg
-9.02%
5Y Avg
-10.48%
Market Cap
$2.02B
Return on Invested Capital (ROIC)
21.77%
TTM Avg
7.57%
3Y Avg
-7.64%
5Y Avg
-15.11%
Market Cap
$1.91B
Return on Invested Capital (ROIC)
-6.53%
TTM Avg
-15.76%
3Y Avg
-21.33%
5Y Avg
-21.68%
Market Cap
$2.04B
Return on Invested Capital (ROIC)
15.47%
TTM Avg
9.87%
3Y Avg
8.85%
5Y Avg
8.76%
Market Cap
$1.90B
Return on Invested Capital (ROIC)
-51.06%
TTM Avg
-99.01%
3Y Avg
-126.31%
5Y Avg
-97.79%
Market Cap
$2.04B
Return on Invested Capital (ROIC)
-89.73%
TTM Avg
-14.48%
3Y Avg
-24.76%
5Y Avg
-41.39%
Market Cap
$1.90B
Return on Invested Capital (ROIC)
-44.21%
TTM Avg
-32.05%
3Y Avg
-35.56%
5Y Avg
-35.59%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | $1.97B | -57.17% | -41.43% | -45.66% | N/A |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.98B | 6.33% | 5.44% | -1.33% | -7.01% |
| AxoGen, Inc. (AXGN)vs › | $1.96B | -4.68% | -2.93% | -9.02% | -10.48% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 21.77% | 7.57% | -7.64% | -15.11% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.91B | -6.53% | -15.76% | -21.33% | -21.68% |
| Progyny, Inc. (PGNY)vs › | $2.04B | 15.47% | 9.87% | 8.85% | 8.76% |
| Immunome, Inc. (IMNM)vs › | $1.90B | -51.06% | -99.01% | -126.31% | -97.79% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.04B | -89.73% | -14.48% | -24.76% | -41.39% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.90B | -44.21% | -32.05% | -35.56% | -35.59% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.05B | 0.62% | -3.84% | -0.68% | -0.08% |
ROIC
-57.2%
ROE
-63.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -57.17% |
| 2026-03-31 | -26.87% |
| 2025-12-31 | -26.38% |
| 2025-09-30 | -31.94% |
| 2025-06-30 | -64.76% |
| 2025-03-31 | -58.99% |
| 2024-12-31 | -100.60% |
| 2024-09-30 | -71.05% |
| 2024-06-30 | -46.37% |
| 2024-03-31 | -32.03% |
| 2023-12-31 | -35.10% |
| 2023-09-30 | -25.36% |
| 2023-06-30 | -16.88% |
| 2023-03-31 | -13.13% |
| 2022-12-31 | -29.59% |
| 2022-09-30 | -24.78% |
